Terumo Blood and Cell Technologies
TrustedOriginally established in 1964 as COBE Laboratories, today, nearly 7,000 associates around the world are deeply committed to our vision of working together for better lives and our promise to unlock the potential of blood and cells. One way we back these words is through our pledge to be a conscientious corporate citizen and conduct our business in a way that provides social, environmental and economic benefit.
At Terumo Blood and Cell Technologies, discovery never stops. We share a passion for thinking in new and different ways and we are proud to support education and research through a variety of community involvement activities as well as by providing grants to advance treatment options for patients. We know the work we do matters and has the potential to fundamentally improve health care. We remain dedicated to ensuring the lifesaving gift of blood is available around the world and to meeting and exceeding the needs of our customers and the patients we ultimately serve.
If you are the best at what you do, we invite you to explore career opportunities with us now!
We have careers in:
• R&D
• IT
• Engineering
• Clinical Sciences
• Manufacturing
• Software Development
• Quality and Regulatory
Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 16
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 5, 2026 | Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint | A collaborative integration model to enable practical, scalable cell and gene therapy delivery. SINGAPORE, March 5, 2026 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) today announced the launch of its new C> Ecosyste... |
| Oct 22, 2025 | The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies | — Second U.S. site to deploy the Reveos™ system, boosting platelet supply and reducing waste LAKEWOOD, Colo., Oct. 22, 2025 /PRNewswire/ -- To help address platelet shortages and streamline blood center operations, The Blood Center in New O... |
| Oct 7, 2025 | Terumo Blood and Cell Technologies Honored with Corporate Excellence Award at the Asia Pacific Enterprise Awards 2025 Regional Edition | SINGAPORE, Oct. 7, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) has been recognized with the Corporate Excellence Award at the Asia Pacific Enterprise Awards (APEA) 2025 Regional Edition organized by Enterprise Asia,... |
| Aug 25, 2025 | Oxford spinout OrganOx acquired by Terumo for $1.5 billion, largest university spinout exit in UK history | OrganOx, the Oxford University spinout that has been quietly reshaping the field of organ transplantation, is being acquired by Tokyo-based Terumo Corporation in a $1.5 billion deal — the largest acquisition of a university spinout in the U... |
| Apr 17, 2025 | Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer | Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth LAKEWOOD, Colo., April 17, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Ter... |
| Feb 27, 2025 | Neuron7 Delivers Resolution Pathways, Transforming Service Delivery with Fast, Accurate Agentic AI Technology That Raises the Standard for Service Excellence | Neuron7.ai, the leader in AI for service resolution intelligence, today announced the general availability of its newest solution, Resolution Pathways. Resolution Pathways transforms static knowledge into interactive, visual step-by-step re... |
| Jan 21, 2025 | The Future of Blood: Unlocking the Potential of Blood and Cells to Transform Healthcare | The mission of Terumo BCT is to unlock the potential of blood and cells to improve patient outcomes and address unmet medical need. If you ever donated blood... you’ve interacted with our technologies” — Antoinette Gawin, President and CEO,... |
| May 9, 2024 | FDA Clears the Individualized Nomogram for Rika Plasma Donation System | The latest innovation is anticipated to increase collection volume without increasing collection time Rika's individualized nomogram, iNomi, can enable plasma donors to donate the right amount of plasma on any given day based on height... |
| Nov 17, 2021 | Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe | The therapy aims to re-energize a patient's immune system to fight cancer tumors Initial commercialization will target leading oncology centers in Germany, France, Italy, and Spain LAKEWOOD, Colo. and SAN DIEGO, Nov. 17, 2021 /PRNewswi... |
Reviews 0
FAQ about Terumo Blood and Cell Technologies
When was Terumo Blood and Cell Technologies founded?
Terumo Blood and Cell Technologies was founded in 1964.
How much funding has Terumo Blood and Cell Technologies raised?
Terumo Blood and Cell Technologies has raised $17.4M in total across 1 funding round.
What has the press written about Terumo Blood and Cell Technologies?
Parsers VC has collected 16 articles mentioning Terumo Blood and Cell Technologies, among them “Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint” (Mar 5, 2026) and “The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies” (Oct 22, 2025).
Is Terumo Blood and Cell Technologies still active?
Yes, Terumo Blood and Cell Technologies is active; its latest activity on Parsers VC dates from Oct 19, 2026.